We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a micro-randomised trial to evaluate your digital health product.
Projects granted during 2016 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
Operating principles for commissioners and providers of night shelters for people experiencing rough sleeping.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
Evidence and guidance to help healthcare professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health.
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
How responders can reduce the risk of communications disruption during emergencies by using ResilienceDirect, HITS and Telecoms Sub-Groups.
Estimates of the cardiovascular disease events and costs avoided from increasing blood pressure checks in community pharmacies in England.
Information about the risks of taking valproate medicines during pregnancy.
Information on methyl ethyl ketone (MEK) (also known as 2-butanone) for use in responding to chemical incidents.
For manufacturers reporting adverse incidents with biological/mechanical surgical heart valves under the vigilance system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).